Wellington Shields Capital Management, LLC Collegium Pharmaceutical, Inc Transaction History

Wellington Shields Capital Management, LLC

$558 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 02, 2018	SELL	$21.79 - $28.29 $174,320 - $226,320	-8,000 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$18.15 - $29.21 $145,200 - $233,680	8,000 New	8,000 $204,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$174 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$79 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$77.6 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$70.3 Million
0.0% of portfolio
Principal Financial Group Inc Des Moines, IA

1.75M
Shares

$52.3 Million
0.04% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account